Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
NCT: NCT05682677 · RECRUITING
Brief Summary
The primary goal of this clinical trial is to evaluate whether Personalized Augmented Cognitive Training (PACT) plus intermittent theta burst stimulation (iTBS) is effective for treating depression in Service Members, Veterans, and civilians who have sustained a mild TBI. Participants will receive PACT plus 20 sessions of iTBS or sham iTBS over 4 weeks. Assessments will occur at baseline, 2 weeks, 4 weeks, and 8 weeks. Researchers will compare the PACT+iTBS group to the PACT+sham iTBS group to see if PACT+iTBS is associated with more depression improvement.
Frequently Asked Questions
What is Combined Neuromodulation and Cognitive Training for Post-mTBI Depression?
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression is a clinical trial registered under NCT05682677. Current status: RECRUITING.
What is the status of NCT05682677?
The current status of NCT05682677 (Combined Neuromodulation and Cognitive Training for Post-mTBI Depression) is: RECRUITING.
When did Combined Neuromodulation and Cognitive Training for Post-mTBI Depression start?
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression started on 2023-09-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.